Literature DB >> 28384319

Correction: Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression.

Howard R Weeks, Scott C Tadler, Kelly W Smith, Eli Iacob, Mikala Saccoman, Andrea T White, Joshua D Landvatter, Gordon J Chelune, Yana Suchy, Elaine Clark, Michael K Cahalan, Lowry Bushnell, Derek Sakata, Alan R Light, Kathleen C Light.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0069809.].

Entities:  

Year:  2017        PMID： 28384319      PMCID： PMC5383332          DOI： 10.1371/journal.pone.0175668

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The following information is missing from the Competing Interests section: At the time of the study, author DS had an equity interest in Anecare, a commercial company, which holds the license to the ANEclear device that was used in the study. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
  1 in total

1.  Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression.

Authors:  Howard R Weeks; Scott C Tadler; Kelly W Smith; Eli Iacob; Mikala Saccoman; Andrea T White; Joshua D Landvatter; Gordon J Chelune; Yana Suchy; Elaine Clark; Michael K Cahalan; Lowry Bushnell; Derek Sakata; Alan R Light; Kathleen C Light
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.